FSSAI Announces New Lab To Test ‘Food For Sportspersons’ Products

New Delhi:  The Food Safety and Standards Authority of India (FSSAI) has announced the notification of an additional laboratory for testing “Food for Sportspersons” for prohibited substances as defined by the World Anti-Doping Agency (WADA). The newly designated laboratory is the Analytical Testing Laboratory at the National Institute of Pharmaceutical Education and Research (NIPER) located in Balanagar, Hyderabad, Telangana.

It is worth noting that FSSAI had recently appointed the Centre of Excellence for Research and Analysis of Narcotic Drugs and Psychotropic Substances (CERANS) as a laboratory for testing “Food for Sportspersons” for the same purpose. With the addition of the Analytical Testing Laboratory at NIPER, two laboratories have been designated for this task.

According to the FSS (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purposes, Functional Food, and Novel Food) Regulations, 2016, no prohibited substances identified by WADA should be included in any food products meant for sportspersons. Food business operators are required to consult the annual list of prohibited substances published by WADA, which is effective from January 1 each year.

The scope of accreditation for the laboratory is categorized as “Chemical.” The current accreditation granted by the National Accreditation Board for Testing and Calibration Laboratories (NABL) allows for testing of prohibited substances declared by WADA under the category of “Chemical-Nutritional Supplement.”

FSSAI has instructed enforcement authorities to utilise the newly notified laboratory for testing “Food for Sportspersons” with an FSSAI license for prohibited substances declared by WADA as needed.

Related Posts

  • Pharma
  • February 11, 2025
  • 114 views
Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?

Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that former U.S. President Donald Trump…

  • Pharma
  • February 11, 2025
  • 78 views
Glenmark secures MHRA approval to launch Winlevi in the UK

Glenmark Pharmaceuticals (Glenmark) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. The topical treatment for acne vulgaris is approved…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?

Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?

Glenmark secures MHRA approval to launch Winlevi in the UK

Glenmark secures MHRA approval to launch Winlevi in the UK

Drug association ties up with NIPER to set up pharma research centre in Baddi

Drug association ties up with NIPER to set up pharma research centre in Baddi

India’s Pharma Industry: Poised for Global Expansion by 2030

India’s Pharma Industry: Poised for Global Expansion by 2030